Suppr超能文献

Jagged1 通过调节乳腺癌患者肿瘤相关巨噬细胞的分化促进芳香酶抑制剂耐药性。

Jagged1 promotes aromatase inhibitor resistance by modulating tumor-associated macrophage differentiation in breast cancer patients.

机构信息

Tumor Hospital of Harbin Medical University, 150 Haping Road, Harbin, Heilongjiang, China.

The Fourth Affiliated Hospital of Harbin Medical University, 37 Yiyuan Street, Harbin, Heilongjiang, China.

出版信息

Breast Cancer Res Treat. 2017 Nov;166(1):95-107. doi: 10.1007/s10549-017-4394-2. Epub 2017 Jul 20.

Abstract

PURPOSE

Endocrine resistance limits the efficacy of anti-estrogen therapies. Notch signaling is involved in modulating tumor-associated macrophage (TAM) differentiation and is upregulated in endocrine-resistant breast cancer cells. Here, we analyzed the role of Jagged1 in the regulation of TAM polarization to investigate whether the Jagged1-Notch pathway promotes the acquisition of aromatase inhibitor (AI) resistance by upregulating TAM infiltration.

METHODS

The Jagged1 expression levels and M2 TAM infiltration density, in 203 tumor samples from ER-positive postmenopausal patients, who received AI treatment, were evaluated by immunohistochemical staining and the results were compared with clincopathological parameters and survival. The Jagged1 protein and mRNA levels were analyzed in MCF-7 and long-term endocrine-depleted (LTED) cell lines. The phenotypes of macrophage after macrophages were co-cultured with either MCF-7 or LTED cells, were evaluated using flow cytometry. Cell migration assay was performed to evaluate the mobility of cancer cells. Notch gama secretase inhibitor (GSI) RO4929097 was employed to investigate whether modulation of Notch signaling affects M2 polarization.

RESULTS

In the tumor samples, Jagged1 expression was found to be associated with a large tumor size, high histological grade, lymphatic invasion, and high Ki67 expression. Jagged1 expression was also correlated with reduced disease-free and overall survival and was positively associated with the stromal M2 TAM infiltration density in primary tumor tissues. In AI-resistance patients, M2 TAM infiltration was denser in metastatic lesions than in primary tumors. Higher Jagged1 protein and mRNA levels were also found in LTED cells, which model AI-resistant conditions in patients, compared with MCF-7 cells. Macrophages co-cultured with LTED cells expressed higher levels of M2 marker and IL-10. M2 TAM proportion was reduced when macrophages were pre-treated with GSI before co-culture.

CONCLUSIONS

The Jagged1-Notch pathway showed elevated expression in AI-resistant breast cancer cells, resulting in macrophage differentiation towards M2 TAMs and there contributing to the acquisition of AI resistance.

摘要

目的

内分泌抵抗限制了抗雌激素治疗的疗效。Notch 信号通路参与调节肿瘤相关巨噬细胞(TAM)分化,并在内分泌抵抗的乳腺癌细胞中上调。在这里,我们分析了 Jagged1 在调节 TAM 极化中的作用,以研究 Jagged1-Notch 通路是否通过上调 TAM 浸润来促进芳香酶抑制剂(AI)耐药的获得。

方法

通过免疫组织化学染色评估 203 例接受 AI 治疗的 ER 阳性绝经后患者肿瘤样本中 Jagged1 的表达水平和 M2 TAM 浸润密度,并将结果与临床病理参数和生存进行比较。分析 MCF-7 和长期内分泌耗竭(LTED)细胞系中 Jagged1 蛋白和 mRNA 水平。使用流式细胞术评估巨噬细胞与 MCF-7 或 LTED 细胞共培养后巨噬细胞的表型。进行细胞迁移实验以评估癌细胞的迁移能力。使用 Notch γ分泌酶抑制剂(GSI)RO4929097 研究 Notch 信号转导的调节是否影响 M2 极化。

结果

在肿瘤样本中,发现 Jagged1 表达与肿瘤体积大、组织学分级高、淋巴浸润和 Ki67 表达高有关。Jagged1 表达与无病生存和总生存降低相关,并且与原发性肿瘤组织中基质 M2 TAM 浸润密度呈正相关。在 AI 耐药患者中,转移性病变中的 M2 TAM 浸润密度比原发性肿瘤中更高。与 MCF-7 细胞相比,模拟患者 AI 耐药条件的 LTED 细胞中 Jagged1 蛋白和 mRNA 水平也更高。与 LTED 细胞共培养的巨噬细胞表达更高水平的 M2 标志物和 IL-10。巨噬细胞在共培养前用 GSI 预处理时,M2 TAM 比例降低。

结论

Jagged1-Notch 通路在 AI 耐药乳腺癌细胞中表达上调,导致巨噬细胞向 M2 TAM 分化,并有助于获得 AI 耐药。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验